antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection

RxCUI: 2275724
RxNorm name: antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection
Display name: antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection
Full name: antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125671	Esperoct	Antihemophilic Factor (Recombinant), GlycoPEGylated-exei	351(a)	Rx	2026-09-01

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Adverse event summaries are temporarily unavailable. Other product information remains available.

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
562f94e8-825f-4d7f-b93c-b783ac3a43bc	antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection [PSN] · antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection [SCD]	2	7	These highlights do not include all the information needed to use ESPEROCT ® safely and effectively. See full prescribing information for ESPEROCT. ESPEROCT [antihemophilic factor (recombinant), glycopegylated-exei] lyophilized powder for solution, for intravenous use Initial U.S. Approval: 2019	20240701